However, the largest of those trials, which showed a trend toward improved survival, was underpowered and included a heterogeneous group of patients in terms of both disease severity and time of onset [ 12 ].
← all excerpts
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.
1
—
—